Skip to main content
Conavi Medical Corp. logo

Conavi Medical Corp. — Investor Relations & Filings

Ticker · CNVI TSXV Manufacturing
Open in API
Filings indexed 346 across all filing types
Latest filing 2026-01-08 Capital/Financing Update
Country CA Canada
Listing TSXV CNVI

About Conavi Medical Corp.

https://www.conavi.com/

Conavi Medical Corp. is a medical device company focused on designing, manufacturing, and marketing image guidance technologies for minimally invasive cardiovascular procedures. Its flagship product is the Novasight Hybrid System, which provides simultaneous, co-registered Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) imaging using a single catheter and pullback. This hybrid approach offers comprehensive visualization of coronary arteries, combining the high resolution of OCT for lumen assessment with the depth of IVUS for vessel wall analysis. The system is intended to guide complex Percutaneous Coronary Interventions (PCIs) by providing additional diagnostic information over single-modality imaging.

Recent filings

Filing Released Lang Actions
Consent letter of issuer's legal counsel.pdf
Capital/Financing Update Classification · 1% confidence The document is a legal consent letter from Mintz LLP regarding an 'Amended and Restated Short Form Prospectus' for Conavi Medical Corp. It is a short, formal correspondence confirming legal review and consent for the inclusion of their name in a prospectus filing. Since it does not fit into specific categories like financial reports, earnings, or shareholder voting, and serves as a regulatory filing document, it is best classified as a general regulatory filing.
2026-01-08 English
Auditors' consent letter.pdf
Capital/Financing Update Classification · 1% confidence The document is an auditor's consent letter provided by MNP LLP regarding a short form prospectus for Conavi Medical Corp. It confirms the auditor's consent to the inclusion of their previous audit report in the new offering document. This type of filing is a standard regulatory requirement for securities offerings and does not fit into the specific categories for financial reports, earnings, or management changes. Therefore, it is classified as a Regulatory Filing.
2026-01-08 English
Auditors' consent letter.pdf
Audit Report / Information Classification · 1% confidence The document is an auditor's consent letter addressed to various Securities Commissions regarding an amended and restated short form prospectus. It confirms the auditor's consent to the inclusion of their report on consolidated financial statements within the offering document. This type of document is a standard regulatory filing associated with capital raising activities and does not constitute the financial report itself, nor does it fit into specific categories like M&A or Board changes. Therefore, it is classified as a Regulatory Filing. FY 2025
2026-01-08 English
Auditors' consent letter.pdf
Audit Report / Information Classification · 1% confidence The document is an auditor's consent letter from BDO Canada LLP regarding a short form prospectus for Conavi Medical Corp. It confirms the auditor's consent to the use of their previous audit reports in the prospectus. This type of document is a standard regulatory filing associated with capital raising activities and does not fit into the specific categories for financial reports, earnings, or management changes. It is a regulatory filing required by securities commissions. FY 2022
2026-01-08 English
Consent letter of underwriters' legal counsel.pdf
Capital/Financing Update Classification · 1% confidence The document is a legal consent letter from Baker & McKenzie LLP regarding an 'Amended and Restated Final Short Form Prospectus' for Conavi Medical Corp. It is filed via SEDAR+ to the Ontario Securities Commission. Since this is a legal opinion/consent document related to a securities offering and does not fit into the specific categories of financial reports or management updates, it falls under the 'Regulatory Filings' category.
2026-01-08 English
Amendment to (or amended) final short form prospectus – English.pdf
Capital/Financing Update Classification · 1% confidence The document is an 'Amended and Restated Short Form Prospectus' for Conavi Medical Corp. It details a public offering of common shares and pre-funded warrants, including pricing, agent commissions, and distribution plans. In financial document classification, a prospectus is a formal legal document required by and filed with securities regulators to provide details about an offering for sale of securities to the public. Within the provided categories, this fits best under 'Capital/Financing Update' (CAP) as it relates to fundraising and capital structure changes, or 'Regulatory Filings' (RNS) as a fallback. Given the specific nature of a prospectus as a capital-raising document, CAP is the most accurate classification.
2026-01-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.